GRACEcast Cancer 101 Audio

GRACEcast Cancer 101 Audio

Por: cancerGRACE - H. Jack West, MD
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
300 episodios disponibles

Latest episodes of the podcast GRACEcast Cancer 101 Audio

Mostrando página 7 de 15

ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (video) 07/08/2013
ASCO Lung Cancer Highlights, Part 1: Introduction to Stage III NSCLC (audio) 07/08/2013
Dr. Bob Doebele: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression? 06/08/2013
Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors 06/08/2013
Dr. David Spigel on "Which molecular marker tests do you seek?" 29/07/2013
HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (video) 22/07/2013
HPV in Head and Neck Cancer, Part 2: Caveats and Emerging Trials (audio) 22/07/2013
HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (video) 22/07/2013
HPV in Head and Neck Cancer, Part 1: What is it and What Does it Mean? (audio) 22/07/2013
Induction Chemotherapy for Head and Neck Cancer, Part 2: New Concepts Moving Forward (video) 21/07/2013
Induction Chemotherapy for Head and Neck Cancer, Part 2: New Concepts Moving Forward (audio) 21/07/2013
Induction Chemotherapy for Head and Neck Cancer, Part 1: Defining the Challenges (video) 18/07/2013
Induction Chemotherapy for Head and Neck Cancer, Part 1: Defining the Challenges (audio) 18/07/2013
Dr. Ravi Salgia: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing? 11/07/2013
Dr. Sarah Goldberg: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers? 11/07/2013
Dr. Bob Doebele on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment 11/07/2013
Drs. Ross Camidge and Corey Langer on "Which patients do you send molecular marker testing for?" 11/07/2013
Dr. Greg Riely: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers? 11/07/2013
Is there a place for maintenance therapy in extensive stage NSCLC? 04/07/2013
How should we integrate new immunotherapies into treatment strategies for lung cancer? 04/07/2013
« Primera ‹ Anterior 1 ... 5 6 7 8 9 ... 15 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA